Positions & Views

At AbbVie, our life’s work is to improve lives, and we pledge to do so in a transparent and sustainable way.

Our position on key issues that affect our business, patients, employees and stakeholders

We support public policies that promote our mission of:

Learn more about on biologic innovation, including our position on biosimilars.

Our commitment to ensure access to medicines and improve the lives of patients.

Let’s accelerate the delivery of new medicines to Canadians – opinion piece by Arima Ventin (Executive Director, Market Access and Government Affairs) published in The Hill Times on April 24, 2023
Achieving Timely Hepatitis C Elimination in Canada – opinion piece by Tracey Ramsay (Vice-President & General Manager, AbbVie Canada) published in The Hill Times on July 25, 2022
Innovation Changes Lives for the Better — opinion piece by Christina Pelizon (Director, Medical Affairs, AbbVie Canada) published in The Hill Times Health Policy Briefing issue on May 9, 2022
Cancer Impacts Everyone – opinion piece by Tracey Ramsay (Vice-President & General Manager, AbbVie Canada) published in The Hill Times Health Policy Briefing issue on April 25, 2022
Five lessons learned from Canadians living with psoriatic arthritis
Pharmaceutical innovation can help Canadians in pain – and the economy
Shining A New, Brighter Light: Three Medication Industry Insights – opinion piece by Denis Hello (former Vice-president & General Manager of AbbVie Canada) published in the Benefits and Pensions Monitor magazine
When you are living with cancer, quick and optimal access to medication can be a matter of life or death – opinion piece by Denis Hello (former Vice-president and General Manager of AbbVie Canada).
Time matters when a cure is possible – opinion piece by Stéphane Lassignardie (former President, AbbVie, Canada)